Skip to main content
logo

SK Biopharmaceuticals Co., Ltd. (KRX:326030)

South Korea flag South Korea · Delayed Price · Currency is KRW
99,600
0.00 (0.00%)
At close: Aug 8, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
New Drugs
547.60B
Log In
Log In
Log In
Log In
Upgrade
New Drugs Growth
54.30%
Log In
Log In
Log In
Log In
Upgrade
Service
-
Log In
Log In
Log In
Log In
Upgrade
Service Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Consolidated Adjustment
-594.66B
Log In
Log In
Log In
Log In
Upgrade
Consolidated Adjustment Growth
27.97%
Log In
Log In
Log In
Log In
Upgrade
United States
667.82B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
31.23%
Log In
Log In
Log In
Log In
Upgrade
South Korea
474.43B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
52.69%
Log In
Log In
Log In
Log In
Upgrade
Consolidated Adjustment
-594.66B
Log In
Log In
Log In
Log In
Upgrade
Consolidated Adjustment Growth
27.97%
Log In
Log In
Log In
Log In
Upgrade
Cayman Islands
-
Log In
Log In
Log In
Log In
Upgrade
Netherlands
-
Log In
Log In
Log In
Log In
Upgrade
Canada
-
Log In
Log In
Log In
Log In
Upgrade
Japan
-
Log In
Log In
Log In
Log In
Upgrade
Ireland
-
Log In
Log In
Log In
Log In
Upgrade